Precision Assessment of Platelet Rich Plasma for Joint Preservation
Key facts
- Who runs it
- VA Office of Research and Development
- Where
- Palo Alto, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 90 people enrolled
- Started
- 2 Apr 2018
- Ended
- 31 Mar 2024
- Type of study
- Observational
- Record updated
- 23 May 2025
Who can take part
- Age
- 30 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- symptomatic early knee OA
- full weight-bearing status
- have elected to receive PRP treatment
- Male veterans
- Female veterans
Who cannot take part
- severe systemic disease defined as American Society of Anesthesiologists (ASA) 3 or above56
- predominantly patellofemoral disease
- inflammatory arthritis, gout or recurrent pseudogout
- symptomatic OA of other lower extremity joints
- BMI >35 kg/m2
- use of walking, orthopedic, or prosthetic assistive device
- inability to have MRI
- pregnant or intending to become pregnant during the study
Where in United States
- VA Palo Alto Health Care System, Palo Alto, CAPalo Alto, United States
About the trial
What the trial wants to find out
Knee Osteoarthritis (OA) is a leading cause of premature disability in Veterans who develop knee OA at higher rates and younger ages than the population in general. For those with symptomatic early knee OA, who are years to decades away from meeting clinical indications for knee replacement surgery, knee injections have been a key treatment option. In recent years, platelet rich plasma (PRP) injections have gained increasing attention for improving pain and function in patients with knee OA. Basic science studies also suggest that PRP may also potentially stimulate repair responses to articular cartilage. However, the mechanisms of action of PRP in the treatment of knee OA are unknown. Because autologous blood is used, the PRP composition differs between patients. It is also unknown whether these differences in PRP composition affect clinical outcomes. This study will address these gaps and provide critical new and objective information on PRP treatment effects in Veterans and additional women with early knee OA important to improving clinical use of this new treatment.
The group in the trial
- PRP
Symptomatic early knee osteoarthritis subjects who have elected to receive PRP treatment.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 23 May 2025